You are here: Industry Insights > Diabetes

News List

Next generation diabetes therapy and drug delivery market expected to reach US$9,673 million, global pharmaasia
May 02, 2017
Next generation diabetes therapy and drug delivery devices are used to check the blood glucose levels and deliver insulin into the body.
Type 2 Diabetes May Be Bad for Brain Health drugs.com
April 28, 2017
Previous research has linked type 2 diabetes and memory loss. Now, new research may be closing in on some of the reasons why.
GeNeuro initiates Phase 2a study in Australia to treat Type 1 Diabetes europeanpharmaceuticalreview
April 20, 2017
GeNeuro, a biopharmaceutical company developing new treatments for neurological disorders and autoimmune diseases, have started a Phase 2a clinical study in Australia with GNbAC1 in patients with Type 1 diabetes.
Plant protein may protect against type II diabetes, meat eaters at greater risk: Study financialexpress
April 20, 2017
Source of dietary protein may play a role in the risk of developing type-II diabetes
SCIENCE CHINA Life Sciences English Edition Publishes Domestic Type 2 Diabetes Research Findings en-cphi.cn
April 17, 2017
SCIENCE CHINA Life Sciences, a scientific journal sponsored by the Chinese Academy of Sciences and the National Natural Science Foundation of China...
Evotec Achieves Sanofi Diabetes Milestone contractpharma
April 07, 2017
Achieves preclinical proof-of-concept, triggering €3.0 million payment
Once-weekly semaglutide demonstrated consistent blood glucose reductions and weight loss regardless worldpharmanews
April 05, 2017
Findings from a post hoc analysis of the phase 3a SUSTAIN 2-4 trials demonstrated greater mean reductions in HbA1c and body weight with once-weekly semaglutide treatment compared to sitagliptin...
Lilly and the William Sansum Diabetes Center announce a five-year research collaboration lilly
March 27, 2017
Jointly developed research projects will study diabetes healthcare outcomes for the Latino population
New analysis shows Novartis Entresto improves glycemic control in reduced ejection fraction heart fa worldpharmanews
March 21, 2017
Novartis has announced results of a new post-hoc analysis in a subgroup of patients with reduced ejection fraction heart failure (HFrEF) and diabetes...
Branded heart, diabetes drugs much costlier than generic ones financialexpress
March 13, 2017
The minster also mentioned that in the diabetes drugs segment the average price of leading brands of some medicines is also higher between 10-3 times the MRP of generic drugs in Jan Aushadhi Kendras

Previous page 1 2 3 4 5 6 7 8 9 10 ... 37 38 Next page